Brain Metastases from Breast Cancer and Response to Treatment with Eribulin: A Case Series

Brain metastases are common in patients with advanced breast cancer (BC), causing considerable morbidity and mortality. Eribulin is a microtubule dynamics inhibitor approved for treating certain patients with metastatic BC, previously treated with an anthracycline and a taxane. In the 301 phase 3 st...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Alex Y, Ying, Xu Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444132/
https://www.ncbi.nlm.nih.gov/pubmed/26052228
http://dx.doi.org/10.4137/BCBCR.S21176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444132/
https://www.ncbi.nlm.nih.gov/pubmed/26052228
http://dx.doi.org/10.4137/BCBCR.S21176

Ejemplares similares